Report cover image

In Vitro Diagnostics Business Outlook, 2024

Publisher Kalorama Information
Published Jan 29, 2024
Length 33 Pages
SKU # KLI18458223

Description

In Vitro Diagnostics Business Outlook, 2024


ISSUE 1 OF 6 - In Vitro Diagnostics Business Outlook, Volume 3, Issue 1 - Focus on Molecular HLA Testing

(price includes 6 issues published every two months)In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.

In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:

Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
  • A comprehensive view of the IVD market with test categories covered and company briefs
  • M&A activities, selected partnerships & collaborations, partnership deals, and more
  • Industry & region watch to help tailor strategies
  • Analysis of news and events and reporting on news not easily available

Table of Contents

33 Pages
MARKET ANALYSIS: MOLECULAR HLA/TRANSPLANT TESTING
OVERVIEW OF MOLECULAR HLA/TRANSPLANT TESTING
MARKET OUTLOOK
REGIONAL MARKET
TOP COMPANY BRIEFS
Immucor
Luminex/DiaSorin
CareDx
Thermo Fisher Scientific
EXECUTIVE NEWS BRIEFING
DEKFI DIAGNOSTICS APPOINT NEW CEO
ONERA RAISES $32 MILLION IN FUNDING
CLEVELAND DIAGNOSTICS COMPLETES $75 MILLION IN FUNDING
FINANCIAL HIGHLIGHTS: AGILENT AND HOLOGIC
AGILENT FULL YEAR FISCAL 2023 SALES UP 1.5% IN CORE BUSINESS YOY
Figure: Agilent Sales, by Business (Agilent CrossLab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), FY 2022 and FY 2023
Figure: Agilent Sales, by Business (Agilent CrossLab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), FY 2023 Quarterly Performance
Table: Agilent Revenue Mix, by Type (Consumables/Services/Informatics and Instruments), FY 2023 (%)
Figure: Agilent FY 2023 Regional Sales Breakdown Distribution, by Region (Americas, Asia Pacific, Europe) (%)
HOLOGIC SUPPORTS STRONG FINANCIAL PERFORMANCE IN FULL-YEAR FISCAL YEAR GUIDANCE
Table: Hologic Diagnostic Sales Performance, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), FY 2023 ($ millions)
Figure: Hologic Revenue, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), FY 2022 and FY 2023 ($ millions)
Figure: Hologic Geographic Revenue Distribution, by Region (Asia Pacific, Europe, United States, All Others), FY 2023 (%)
DIAGNOSTIC MARKET MERGERS, ACQUISITIONS AND PARTNERSHIP DEALS
MERGERS AND ACQUISITIONS
Table: Selected Diagnostic Market Mergers and Acquisitions Deals
PARTNERSHIPS AND COLLABORATIONS
INDUSTRY WATCH
COVID-19 UPDATE
REGION WATCH
INDIA
Figure: India Real GDP Growth, Inflation Rate (consumer prices), 2017-2024
Figure: India IVD Market Distribution of Sales, by Broad IVD Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-of-Care Glucose, Other Segments), 2023 (%)
SAUDI ARABIA
Figure: Saudi Arabia Population Pyramid, 2023 and 2053
Figure: Saudi Arabia Total Annual Liquid Fuels Production and Consumption, 2013-2022 (millions of barrels)
Figure: Saudi Arabia IVD Market Share, by Broad IVD Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-of-Care Glucose, Other Segments), 2023
BROAD-BASED COMPANY ANNOUNCEMENTS
QUIDELORTHO OBTAINS FDA NOD
ILLUMINA PLANS TO DIVEST GRAIL
ROCHE TO ACQUIRE LUMIRADX
QIAGEN EXPANDS FOOTPRINT WITH NEW REGIONAL HEADQUARTERS IN MIDDLE EAST

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us